Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India
[299 Pages Report] The global IV therapy and vein access devices market garnered US$ 24.3 Billion in 2021, and is likely to exhibit a Y-o-Y increase of 6.1% to be valued at US$ 25.8 Billion in 2022. Owing to the growing support from various governmental organizations, the market is likely to propel to US$ 44.4 Billion by 2032. The trade is projected at a 5.6% CAGR during the forecast period.
“Increasing number of surgical procedures all over the world, and increasing usage of intravenous therapy devices and equipment, is expected to fuel the demand of IV Therapy and Vein Access Devices Market over the forecast period”.
Attributes | Details |
---|---|
Global IV Therapy and Vein Access Devices Market CAGR (2022-2032) | 5.6% |
Global IV Therapy and Vein Access Devices Market (2032) | US$ 44.4 Billion |
Global IV Therapy and Vein Access Devices Market Attraction | The rising number of intravenous (IV) drug approvals and increasing technological advancements in intravenous therapy (IV) and vein access are expected to drive the market in the forecast period. |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Increasing Prevalence of the Chronic Disease Across the World to Boost IV Therapy and Vein Access Devices Market in Coming Years.
IV therapy is used to deliver a wide range of medications for chronic conditions such as rheumatoid arthritis, Crohn's disease, osteoporosis, systemic lupus, multiple sclerosis, psoriasis, and gout.
The growth of the IV therapy and vein access devices market can be attributed to factors such as the increasing incidences of chronic diseases, the growing number of surgeries worldwide, the rising number of intravenous (IV) drug approvals as well as increasing technological advancements in IV therapy and vein access devices.
Also, increasing healthcare expenditure and healthcare insurance are expected to fuel the IV therapy and vein access devices market growth during the forecast period. Growing critical care therapies and the increase in the geriatric population are the key factors that provide growth opportunities to IV therapy and vein access devices market.
Despite the growing popularity of IV therapy and vein access devices, there are various factors that are likely to pose a threat to the growth of the IV therapy and vein access devices market during the forecast period.
Prolonged hospitalization required before the placement of the intravenous access devices and cumbersome procedure of inserting the devices is some of the prominent factors anticipated to hinder the market's growth during the forecast period. The complications associated with intravenous therapy as well as a lack of experienced healthcare professionals are projected to have a negative impact on the growth of the IV therapy and vein access devices market.
The increasing technological advancements in intravenous therapy (IV) and vein access and the increasing demand for advanced techniques, such as needleless administration of drugs is also vital driver for this market. IV therapy and vein access devices are used for fluid infusion, blood transfusion, administration of drugs, venous pressure monitoring, and blood sampling.
Also, rising expenditure on healthcare and an increasing number of specialty clinics and ambulatory centers will further expand the size the of IV therapy and vein access devices market in the future.
Growing government focus on advanced healthcare systems, joint efforts by supply chain executives to increase efficiency, and rising government support in developed economies is creating high potential growth opportunities for players operating in the global IV therapy and vein access devices market.
The global market for IV therapy and vein access devices is expected to witness moderate growth over the forecast period. Among the four treatment types, the Intravenous Catheters segment is expected to lead in the global IV therapy and vein access devices market over the forecast period.
Medication Administration is expected to contribute a considerable high share in the global IV therapy and vein access devices market as they are the most accessible channel.
IV Therapy and Vein Access Devices Market:
Attributes | IV Therapy and Vein Access Devices Market |
---|---|
CAGR (2022-2032) | 5.6% |
Market Value (2032) | US$ 44.4 Billion |
Growth Factor | Rising expenditure on healthcare, growing awareness about healthcare procedures, and an increasing number of specialty clinics and ambulatory centers are expected to drive the market in the forecast period. |
Opportunity | Increasing incidences of chronic diseases, the growing number of surgeries worldwide is expected to offer significant opportunities to the market. |
Infusion Pump Market:
Attributes | Infusion Pump Market |
---|---|
CAGR (2022-2032) | 5.0% |
Market Value (2032) | US$ 6.6 Billion |
Growth Factor | The growing incidence of chronic diseases, like cancer and others, together with the increasing adoption of these devices is expected to drive the market in the forecast period. |
Opportunity | Rapid technological innovations are projected to encourage companies to develop more user-friendly and technologically advanced infusion systems is expected to give significant opportunities to the market in the assessment period. |
Peripheral Intravenous Catheter Market:
Attributes | Peripheral Intravenous Catheter Market |
---|---|
CAGR (2022-2032) | 6.1% |
Market Value (2032) | US$ 9.2 Million |
Growth Factor | Increasing disease prevalence and rising incidences of infection are expected to drive the market |
Opportunity | Increased spending on healthcare and advancements in healthcare infrastructure will continue to hold a positive influence on market growth. |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
By Type, Demand for Intravenous Catheters to flourish significantly
Based on the type, the Intravenous catheters segment is expected to dominate the market in the forecast period. The segment is projected to exhibit a CAGR of 5.5% during the forecast period. The segment is expected to have experienced a CAGR of 6.3% during the timeframe of 2015-2021.
Intravenous catheters have a broad range of applications, due to which the market share for Intravenous Catheters is the maximum in comparison to the other products. The user-friendly material composition of intravenous catheters compared to other counterparts is another factor that makes them a preferred choice among physicians as well as patients.
Intravenous catheters are considered ideal for easy, direct administration of antibiotics, IVs, analgesics, and psycholeptics, and preventing blood-borne pathogenic infections will also boost the segment.
Medication Administration to be the Dominant Medical Application Segment
As per the analysis, by medical application, the medication administration segment is expected to lead the market during the forecast period. The segment is anticipated to have witnessed a 6.1% CAGR from 2015 to 2021.
Whereas, during the forecast period, the segment is estimated at a 5.6% CAGR. The medical administration segment is expected to lead the market owing to factors such as the availability of skilled professionals to handle IV therapy and vein access devices.
Technological advancements in the treatment due to need for rapid recovery time and reduced pain while performing procedures and surgeries has strengthened the market. This in turn resulting into growth in demand for IV therapy and vein access devices market in forecasting period.
North America is anticipated to lead the global IV therapy and vein access devices market during the forecast period. Within the North American landscape, the U.S market is likely to garner US$ 15.9 Billion while exhibiting a CAGR of 5.4% from 2022 to 2032.
North America is expected to hold a large share in the global IV therapy and vein access devices market due to the increasing number of surgeries and the presence of leading technological advancements in the healthcare sector.
Europe accounts for a significant share of the global IV therapy and vein access devices market due to increasing expansions witnessed in its major countries. Also, increasing awareness and greater spending on healthcare treatments and procedures.
With such as acceleration in the healthcare industry, manufacturers of IV therapy and vein access devices are focusing on leading economies to strengthen their market footprint globally. The U.K is expected to be most promising across the continent, accumulating US$ 1.8 Billion in revenue terms, growing at a 4.3% CAGR.
The increasing prevalence of kidney disorders & diabetes drives the demand for the IV therapy and vein access devices market in Europe. For instance In March 2021 – B. Braun Avitum AG, and CytoSorbents Corporation commercialized its CytoSorb® blood purification technology to treat deadly inflammation, The CytoSorb® adsorber is used in critical care for the extracorporeal removal of cytokines and inflammatory mediators from the bloodstream and can be operated with the B. Braun OMNI® acute dialysis machine countries worldwide.
APAC is anticipated to be the fastest-growing region during the forecast period. China is likely to make the most significant contribution to developing the market. China is estimated at US$ 3.2 Billion, expanding at a 4.9% CAGR during the forecast period. The growth of the market can be attributed to the presence of evolving countries such as; India, China, Japan, and others.
Increasing prevalence of lifestyle diseases such as diabetes in china the demand for IV therapy and vein access devices is expected to rise. For instance, according to the International Diabetes Federation(IDF) there are around 425 million adults living with diabetes – 114 million cases are in china due to unhealthy habits and lack of physical activity.
In addition, Japan has been recognized as another potent player in the region. According to the analysis, the country is anticipated at US$ 2.6Billion while recording a CAGR of 4.0% in the forecast period. The development of the regional market can be credited to the rapid development in the concerned field. South Korea is estimated to be valued at US$ 1.6 Million, growing at a 3.5% CAGR from 2022-2032.
Countries | Estimated CAGR |
---|---|
USA | 5.4% |
U.K | 4.3% |
China | 4.9% |
Japan | 4.0% |
South Korea | 3.5% |
Eminent players of the global IV Therapy and Vein Access Devices Market include Becton, Dickinson and Company, B. Braun Holding Gmbh & Co. Kg, Terumo Medical Corporation, Teleflex Medical Inc., and Medtronic Inc. among others.
Recent key developments among players include:
Report Attribute | Details |
---|---|
Growth Rate | CAGR of 5.6% from 2022 to 2032 |
Market Value in 2021 | US$ 24.3 Billion |
Market Value in 2022 | US$ 25.8 Billion |
Market Value in 2032 | US$ 44.4 Billion |
Base Year for Estimation | 2021 |
Historical Data | 2015 to 2021 |
Forecast Period | 2022 to 2032 |
Quantitative Units | USD Million for Value |
Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
Segments Covered |
|
Regions Covered |
|
Key Countries Profiled |
|
Key Companies Profiled |
|
Report Customization & Pricing | Available upon Request |
The global IV therapy and vein access devices market is likely to value US$ 24.3Billion in 2021.
The global IV therapy and vein access devices market is estimated to grow at a CAGR of 5.6% from 2022 to 2032.
The global IV therapy and vein access devices market is predicted to procure US$ 44.4 Billion from 2022 to 2032.
The intravenous catheters segment is projected to expand at a 5.5% CAGR during the forecast period.
The medical administration segment is likely to exhibit a 5.6% CAGR from 2022-2032
The main players of IV therapy and vein access devices includes Becton, Dickinson and Company, B. Braun Holding Gmbh & Co. Kg, Terumo Medical Corporation, Teleflex Medical Inc., and Medtronic Inc.
The U.S market is expected to garner US$ 15.9Billion while expanding at a 5.4% CAGR from 2022 to 2032
1. Executive Summary 1.1. Global Market Outlook 1.2. Summary of Statistics 1.3. Key Market Characteristics & Attributes 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on Intravenous (IV) Therapy and Vein Access Devices 3.1.2. COVID-19 Impact Benchmark with Previous Crisis 3.1.3. Impact on Market Value (US$ Mn) 3.1.4. Assessment by Key Countries 3.1.5. Assessment by Key Market Segments 3.1.6. Action Points and Recommendation for Suppliers 3.2. Key Trends Impacting the Market 3.3. Formulation and Product Development Trends 4. Market Background 4.1. Market, by Key Countries 4.2. Market Opportunity Assessment (US$ Mn) 4.2.1. Total Available Market 4.2.2. Serviceable Addressable Market 4.2.3. Serviceable Obtainable Market 4.3. Market Scenario Forecast 4.3.1. Demand in optimistic Scenario 4.3.2. Demand in Likely Scenario 4.3.3. Demand in Conservative Scenario 4.4. Investment Feasibility Analysis 4.4.1. Investment in Established Markets 4.4.1.1. In Short Term 4.4.1.2. In Long Term 4.4.2. Investment in Emerging Markets 4.4.2.1. In Short Term 4.4.2.2. In Long Term 4.5. Forecast Factors - Relevance & Impact 4.5.1. Top Companies Historical Growth 4.5.2. Growth in Automation, By Country 4.5.3. Patch Management Adoption Rate, By Country 4.6. Market Dynamics 4.6.1. Market Driving Factors and Impact Assessment 4.6.2. Prominent Market Challenges and Impact Assessment 4.6.3. Patch Management Market Opportunities 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment 5. Key Success Factors 5.1. Manufacturers’ Focus on Low Penetration High Growth Markets 5.2. Banking on with Segments High Incremental Opportunity 5.3. Peer Benchmarking 6. Global Market Demand Analysis 2015-2021 and Forecast, 2022-2032 6.1. Historical Market Analysis, 2015-2021 6.2. Current and Future Market Projections, 2022-2032 6.3. Y-o-Y Growth Trend Analysis 7. Global Market Value Analysis 2015-2021 and Forecast, 2022-2032 7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021 7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Type 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Mn) Analysis By Type, 2015-2021 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Type, 2022-2032 8.3.1. Implantable Ports 8.3.1.1. Single Lumen Implantable Port 8.3.1.2. Double Lumen Implantable Port 8.3.2. Intravenous Catheters 8.3.2.1. Peripheral Intravenous Catheter 8.3.2.2. Central Intravenous Catheter 8.3.2.3. Peripherally Inserted Central Catheter 8.3.3. Hypodermic Needles 8.3.4. Infusion Pumps 8.3.5. Other Products 8.4. Market Attractiveness Analysis By Type 9. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Medical Application 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) Analysis By Medical Application, 2015-2021 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Medical Application, 2022-2032 9.3.1. Volume Expanders 9.3.2. Medication Administration 9.3.3. Blood-based Products 9.3.4. Nutrition &Buffer Solution 9.4. Market Attractiveness Analysis By Medical Application 10. Global Market Analysis 2015-2021 and Forecast 2022-2032, By End-User 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By End-User, 2015-2021 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End-User, 2022-2032 10.3.1. Hospitals 10.3.2. Ambulatory Surgical Centers 10.3.3. Clinics 10.4. Market Attractiveness Analysis By End-User 11. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Region 11.1. Introduction 11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021 11.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032 11.3.1. North America 11.3.2. Latin America 11.3.3. Europe 11.3.4. Asia Pacific 11.3.5. Middle East and Africa (MEA) 11.4. Market Attractiveness Analysis By Region 12. North America Market Analysis 2015-2021 and Forecast 2022-2032 12.1. Introduction 12.2. Pricing Analysis 12.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 12.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 12.4.1. By Country 12.4.1.1. U.S. 12.4.1.2. Canada 12.4.1.3. Rest of North America 12.4.2. By Type 12.4.3. By End-User 12.4.4. By Medical Application 12.5. Market Attractiveness Analysis 12.5.1. By Country 12.5.2. By Type 12.5.3. By End-User 12.5.4. By Medical Application 13. Latin America Market Analysis 2015-2021 and Forecast 2022-2032 13.1. Introduction 13.2. Pricing Analysis 13.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 13.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 13.4.1. By Country 13.4.1.1. Brazil 13.4.1.2. Mexico 13.4.1.3. Rest of Latin America 13.4.2. By Type 13.4.3. By End-User 13.4.4. By Medical Application 13.5. Market Attractiveness Analysis 13.5.1. By Country 13.5.2. By Type 13.5.3. By End-User 13.5.4. By Medical Application 14. Europe Market Analysis 2015-2021 and Forecast 2022-2032 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 14.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 14.4.1. By Country 14.4.1.1. Germany 14.4.1.2. France 14.4.1.3. U.K. 14.4.1.4. Italy 14.4.1.5. Benelux 14.4.1.6. Nordic Countries 14.4.1.7. Rest of Europe 14.4.2. By Type 14.4.3. By End-User 14.4.4. By Medical Application 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By Type 14.5.3. By End-User 14.5.4. By Medical Application 15. Asia Pacific Market Analysis 2015-2021 and Forecast 2022-2032 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 15.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 15.4.1. By Country 15.4.1.1. China 15.4.1.2. Japan 15.4.1.3. South Korea 15.4.1.4. Rest of Asia Pacific 15.4.2. By Type 15.4.3. By End-User 15.4.4. By Medical Application 15.5. Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By Type 15.5.3. By End-User 15.5.4. By Medical Application 16. Middle East and Africa Market Analysis 2015-2021 and Forecast 2022-2032 16.1. Introduction 16.2. Pricing Analysis 16.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 16.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 16.4.1. By Country 16.4.1.1. GCC Countries 16.4.1.2. South Africa 16.4.1.3. Turkey 16.4.1.4. Rest of Middle East and Africa 16.4.2. By Type 16.4.3. By End-User 16.4.4. By Medical Application 16.5. Market Attractiveness Analysis 16.5.1. By Country 16.5.2. By Type 16.5.3. By End-User 16.5.4. By Medical Application 17. Key Countries Market Analysis 2015-2021 and Forecast 2022-2032 17.1. Introduction 17.1.1. Market Value Proportion Analysis, By Key Countries 17.1.2. Global Vs. Country Growth Comparison 17.2. US Market Analysis 17.2.1. Value Proportion Analysis by Market Taxonomy 17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 17.2.2.1. By Type 17.2.2.2. By End-User 17.2.2.3. By Medical Application 17.3. Canada Market Analysis 17.3.1. Value Proportion Analysis by Market Taxonomy 17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 17.3.2.1. By Type 17.3.2.2. By End-User 17.3.2.3. By Medical Application 17.4. Mexico Market Analysis 17.4.1. Value Proportion Analysis by Market Taxonomy 17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 17.4.2.1. By Type 17.4.2.2. By End-User 17.4.2.3. By Medical Application 17.5. Brazil Market Analysis 17.5.1. Value Proportion Analysis by Market Taxonomy 17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 17.5.2.1. By Type 17.5.2.2. By End-User 17.5.2.3. By Medical Application 17.6. Germany Market Analysis 17.6.1. Value Proportion Analysis by Market Taxonomy 17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 17.6.2.1. By Type 17.6.2.2. By End-User 17.6.2.3. By Medical Application 17.7. France Market Analysis 17.7.1. Value Proportion Analysis by Market Taxonomy 17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 17.7.2.1. By Type 17.7.2.2. By End-User 17.7.2.3. By Medical Application 17.8. Italy Market Analysis 17.8.1. Value Proportion Analysis by Market Taxonomy 17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 17.8.2.1. By Type 17.8.2.2. By End-User 17.8.2.3. By Medical Application 17.9. BENELUX Market Analysis 17.9.1. Value Proportion Analysis by Market Taxonomy 17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 17.9.2.1. By Type 17.9.2.2. By End-User 17.9.2.3. By Medical Application 17.10. UK Market Analysis 17.10.1. Value Proportion Analysis by Market Taxonomy 17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 17.10.2.1. By Type 17.10.2.2. By End-User 17.10.2.3. By Medical Application 17.11. Nordic Countries Market Analysis 17.11.1. Value Proportion Analysis by Market Taxonomy 17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 17.11.2.1. By Type 17.11.2.2. By End-User 17.11.2.3. By Medical Application 17.12. China Market Analysis 17.12.1. Value Proportion Analysis by Market Taxonomy 17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 17.12.2.1. By Type 17.12.2.2. By End-User 17.12.2.3. By Medical Application 17.13. Japan Market Analysis 17.13.1. Value Proportion Analysis by Market Taxonomy 17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 17.13.2.1. By Type 17.13.2.2. By End-User 17.13.2.3. By Medical Application 17.14. South Korea Market Analysis 17.14.1. Value Proportion Analysis by Market Taxonomy 17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 17.14.2.1. By Type 17.14.2.2. By End-User 17.14.2.3. By Medical Application 17.15. GCC Countries Market Analysis 17.15.1. Value Proportion Analysis by Market Taxonomy 17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 17.15.2.1. By Type 17.15.2.2. By End-User 17.15.2.3. By Medical Application 17.16. South Africa Market Analysis 17.16.1. Value Proportion Analysis by Market Taxonomy 17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 17.16.2.1. By Type 17.16.2.2. By End-User 17.16.2.3. By Medical Application 17.17. Turkey Market Analysis 17.17.1. Value Proportion Analysis by Market Taxonomy 17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 17.17.2.1. By Type 17.17.2.2. By End-User 17.17.2.3. By Medical Application 17.17.3. Competition Landscape and Player Concentration in the Country 18. Market Structure Analysis 18.1. Market Analysis by Tier of Companies 18.2. Market Concentration 18.3. Market Share Analysis of Top Players 18.4. Market Presence Analysis 18.4.1. By Regional footprint of Players 18.4.2. Product footprint by Players 19. Competition Analysis 19.1. Competition Dashboard 19.2. Competition Benchmarking 19.3. Competition Deep Dive 19.3.1. BECTON, DICKINSON AND COMPANY 19.3.1.1. Overview 19.3.1.2. Product Portfolio 19.3.1.3. Sales Footprint 19.3.1.4. Strategy Overview 19.3.2. B. Braun Holding GmbH & Co. KG 19.3.2.1. Overview 19.3.2.2. Product Portfolio 19.3.2.3. Sales Footprint 19.3.2.4. Strategy Overview 19.3.3. TERUMO MEDICAL CORPORATION 19.3.3.1. Overview 19.3.3.2. Product Portfolio 19.3.3.3. Sales Footprint 19.3.3.4. Strategy Overview 19.3.4. TELEFLEX MEDICAL INC. 19.3.4.1. Overview 19.3.4.2. Product Portfolio 19.3.4.3. Sales Footprint 19.3.4.4. Strategy Overview 19.3.5. MEDTRONIC INC. 19.3.5.1. Overview 19.3.5.2. Product Portfolio 19.3.5.3. Sales Footprint 19.3.5.4. Strategy Overview 19.3.6. SMITH & NEPHEW PLC. 19.3.6.1. Overview 19.3.6.2. Product Portfolio 19.3.6.3. Sales Footprint 19.3.6.4. Strategy Overview 19.3.7. ANGIODYNAMICS, INC. 19.3.7.1. Overview 19.3.7.2. Product Portfolio 19.3.7.3. Sales Footprint 19.3.7.4. Strategy Overview 19.3.8. PFIZER INC. 19.3.8.1. Overview 19.3.8.2. Product Portfolio 19.3.8.3. Sales Footprint 19.3.8.4. Strategy Overview 19.3.9. INSULET CORPORATION 19.3.9.1. Overview 19.3.9.2. Product Portfolio 19.3.9.3. Sales Footprint 19.3.9.4. Strategy Overview 19.3.10. FRESENIUS SE & CO. KGAA 19.3.10.1. Overview 19.3.10.2. Product Portfolio 19.3.10.3. Sales Footprint 19.3.10.4. Strategy Overview 20. Assumptions and Acronyms Used 21. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Table 01: Global Market Value (US$ Mn), By Type, 2015 – 2021 Table 02: Global Market Value (US$ Mn), By Type, 2022 – 2032 Table 03: Global Market Value (US$ Mn), By End-User, 2015 – 2021 Table 04: Global Market Value (US$ Mn), By End-User, 2022 – 2032 Table 05: Global Market Value (US$ Mn), By Medical Application, 2015 – 2021 Table 06: Global Market Value (US$ Mn), By Medical Application, 2022 – 2032 Table 07: Global Market, By Region, 2015 – 2021 Table 08: Global Market, By Region, 2022 – 2032 Table 09: North America Market Value (US$ Mn), By Type, 2015 – 2021 Table 10: North America Market Value (US$ Mn), By Type, 2022 – 2032 Table 11: North America Market Value (US$ Mn), By End-User, 2015 – 2021 Table 12: North America Market Value (US$ Mn), By End-User, 2022 – 2032 Table 13: North America Market Value (US$ Mn), By Medical Application, 2015 – 2021 Table 14: North America Market Value (US$ Mn), By Medical Application, 2022 – 2032 Table 15: North America Market, By Country, 2015 – 2021 Table 16: North America Market, By Country, 2022 – 2032 Table 17: Latin America Market Value (US$ Mn), By Type, 2015 – 2021 Table 18: Latin America Market Value (US$ Mn), By Type, 2022 – 2032 Table 19: Latin America Market Value (US$ Mn), By End-User, 2015 – 2021 Table 20: Latin America Market Value (US$ Mn), By End-User, 2022 – 2032 Table 21: Latin America Market Value (US$ Mn), By Medical Application, 2015 – 2021 Table 22: Latin America Market Value (US$ Mn), By Medical Application, 2022 – 2032 Table 23: Latin America Market, By Country, 2015 – 2021 Table 24: Latin America Market, By Country, 2022 – 2032 Table 25: Europe Market Value (US$ Mn), By Type, 2015 – 2021 Table 26: Europe Market Value (US$ Mn), By Type, 2022 – 2032 Table 27: Europe Market Value (US$ Mn), By End-User, 2015 – 2021 Table 28: Europe Market Value (US$ Mn), By End-User, 2022 – 2032 Table 29: Europe Market Value (US$ Mn), By Medical Application, 2015 – 2021 Table 30: Europe Market Value (US$ Mn), By Medical Application, 2022 – 2032 Table 31: Europe Market, By Country, 2015 – 2021 Table 32: Europe Market, By Country, 2022 – 2032 Table 33: Asia Pacific Market Value (US$ Mn), By Type, 2015 – 2021 Table 34: Asia Pacific Market Value (US$ Mn), By Type, 2022 – 2032 Table 35: Asia Pacific Market Value (US$ Mn), By End-User, 2015 – 2021 Table 36: Asia Pacific Market Value (US$ Mn), By End-User, 2022 – 2032 Table 37: Asia Pacific Market Value (US$ Mn), By Medical Application, 2015 – 2021 Table 38: Asia Pacific Market Value (US$ Mn), By Medical Application, 2022 – 2032 Table 39: Asia Pacific Market, By Country, 2015 – 2021 Table 40: Asia Pacific Market, By Country, 2022 – 2032 Table 41: MEA Market Value (US$ Mn), By Type, 2015 – 2021 Table 42: MEA Market Value (US$ Mn), By Type, 2022 – 2032 Table 43: MEA Market Value (US$ Mn), By End-User, 2015 – 2021 Table 44: MEA Market Value (US$ Mn), By End-User, 2022 – 2032 Table 45: MEA Market Value (US$ Mn), By Medical Application, 2015 – 2021 Table 46: MEA Market Value (US$ Mn), By Medical Application, 2022 – 2032 Table 47: MEA Market, By Country, 2015 – 2021 Table 48: MEA Market, By Country, 2022 – 2032 Table 49: Global Market Incremental $ Opportunity, By Type, 2015 - 2021 Table 50: Global Market Incremental $ Opportunity, By End-User, 2022 – 2032 Table 51: Global Market Incremental $ Opportunity, By Medical Application, 2015 - 2021 Table 52: Global Market Incremental $ Opportunity, By Region, 2022 – 2032 Table 53: North America Market Incremental $ Opportunity, By Type, 2015 - 2021 Table 54: North America Market Incremental $ Opportunity, By End-User, 2022 – 2032 Table 55: North America Market Incremental $ Opportunity, By Medical Application, 2015 – 2021 Table 56: North America Market Incremental $ Opportunity, By Country, 2022 – 2032 Table 57: Latin America Market Incremental $ Opportunity, By Type, 2015 - 2021 Table 58: Latin America Market Incremental $ Opportunity, By End-User, 2022 – 2032 Table 59: Latin America Market Incremental $ Opportunity, By Medical Application, 2015 - 2021 Table 60: Latin America Market Incremental $ Opportunity, By Country, 2022 – 2032 Table 61: Europe Market Incremental $ Opportunity, By Type, 2015 - 2021 Table 62: Europe Market Incremental $ Opportunity, By End-User, 2022 – 2032 Table 63: Europe Market Incremental $ Opportunity, By Medical Application, 2015 - 2021 Table 64: Europe Market Incremental $ Opportunity, By Country, 2022 - 2032 Table 65: Asia Pacific Market Incremental $ Opportunity, By Type, 2015 - 2021 Table 66: Asia Pacific Market Incremental $ Opportunity, By End-User, 2022 – 2032 Table 67: Asia Pacific Market Incremental $ Opportunity, By Medical Application, 2015 - 2021 Table 68: Asia Pacific Market Incremental $ Opportunity, By Country, 2022 – 2032 Table 69: MEA Market Incremental $ Opportunity, By Type, 2015 - 2021 Table 70: MEA Market Incremental $ Opportunity, By End-User, 2022 – 2032 Table 71: MEA Market Incremental $ Opportunity, By Medical Application, 2015 - 2021 Table 72: MEA Market Incremental $ Opportunity, By Country, 2022 - 2032
Figure 01: Global Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032 Figure 02: Global Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn Figure 03: Global Market Share, By Type, 2022 & 2032 Figure 04: Global Market Y-o-Y Growth Projections, By Type – 2022-2032 Figure 05: Global Market Attractiveness Index, By Type – 2022-2032 Figure 06: Global Market Share, By End-User, 2022 & 2032 Figure 07: Global Market Y-o-Y Growth Projections, By End-User – 2022-2032 Figure 08: Global Market Attractiveness Index, By End-User – 2022-2032 Figure 09: Global Market Share, By Medical Application, 2022 & 2032 Figure 10: Global Market Y-o-Y Growth Projections, By Medical Application – 2022-2032 Figure 11: Global Market Attractiveness Index, By Medical Application – 2022-2032 Figure 12: Global Market Share, By Region, 2022 & 2032 Figure 13: Global Market Y-o-Y Growth Projections, By Region – 2022-2032 Figure 14: Global Market Attractiveness Index, By Region – 2022-2032 Figure 15: North America Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032 Figure 16: North America Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022–2032),US$ Mn Figure 17: North America Market Share, By Type, 2022 & 2032 Figure 18: North America Market Y-o-Y Growth Projections, By Type – 2022-2032 Figure 19: North America Market Attractiveness Index, By Type – 2022-2032 Figure 20: North America Market Share, By End-User, 2022 & 2032 Figure 21: North America Market Y-o-Y Growth Projections, By End-User – 2022-2032 Figure 22: North America Market Attractiveness Index, By End-User – 2022-2032 Figure 23: North America Market Share, By Medical Application, 2022 & 2032 Figure 24: North America Market Y-o-Y Growth Projections, By Medical Application – 2022-2032 Figure 25: North America Market Attractiveness Index, By Medical Application – 2022-2032 Figure 26: North America Market Share, By Country, 2022 & 2032 Figure 27: North America Market Y-o-Y Growth Projections, By Country – 2022-2032 Figure 28: North America Market Attractiveness Index, By Country – 2022-2032 Figure 29: Latin America Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032 Figure 30: Latin America Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022–2032), US$ Mn Figure 31: Latin America Market Share, By Type, 2022 & 2032 Figure 32: Latin America Market Y-o-Y Growth Projections, By Type – 2022-2032 Figure 33: Latin America Market Attractiveness Index, By Type – 2022-2032 Figure 34: Latin America Market Share, By End-User, 2022 & 2032 Figure 35: Latin America Market Y-o-Y Growth Projections, By End-User – 2022-2032 Figure 36: Latin America Market Attractiveness Index, By End-User – 2022-2032 Figure 37: Latin America Market Share, By Medical Application, 2022 & 2032 Figure 38: Latin America Market Y-o-Y Growth Projections, By Medical Application – 2022-2032 Figure 39: Latin America Market Attractiveness Index, By Medical Application – 2022-2032 Figure 40: Latin America Market Share, By Country, 2022 & 2032 Figure 41: Latin America Market Y-o-Y Growth Projections, By Country – 2022-2032 Figure 42: Latin America Market Attractiveness Index, By Country – 2022-2032 Figure 43: Europe Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032 Figure 44: Europe Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022–2032), US$ Mn Figure 45: Europe Market Share, By Type, 2022 & 2032 Figure 46: Europe Market Y-o-Y Growth Projections, By Type – 2022-2032 Figure 47: Europe Market Attractiveness Index, By Type – 2022-2032 Figure 48: Europe Market Share, By End-User, 2022 & 2032 Figure 49: Europe Market Y-o-Y Growth Projections, By End-User – 2022-2032 Figure 50: Europe Market Attractiveness Index, By End-User – 2022-2032 Figure 51: Europe Market Share, By Medical Application, 2022 & 2032 Figure 52: Europe Market Y-o-Y Growth Projections, By Medical Application – 2022-2032 Figure 53: Europe Market Attractiveness Index, By Medical Application – 2022-2032 Figure 54: Europe Market Share, By Country, 2022 & 2032 Figure 55: Europe Market Y-o-Y Growth Projections, By Country – 2022-2032 Figure 56: Europe Market Attractiveness Index, By Country – 2022-2032 Figure 57: MEA Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032 Figure 58: MEA Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022–2032), US$ Mn Figure 59: MEA Market Share, By Type, 2022 & 2032 Figure 60: MEA Market Y-o-Y Growth Projections, By Type – 2022-2032 Figure 61: MEA Market Attractiveness Index, By Type – 2022-2032 Figure 62: MEA Market Share, By End-User, 2022 & 2032 Figure 63: MEA Market Y-o-Y Growth Projections, By End-User – 2022-2032 Figure 64: MEA Market Attractiveness Index, By End-User – 2022-2032 Figure 65: MEA Market Share, By Medical Application, 2022 & 2032 Figure 66: MEA Market Y-o-Y Growth Projections, By Medical Application – 2022-2032 Figure 67: MEA Market Attractiveness Index, By Medical Application – 2022-2032 Figure 68: MEA Market Share, By Country, 2022 & 2032 Figure 69: MEA Market Y-o-Y Growth Projections, By Country – 2022-2032 Figure 70: MEA Market Attractiveness Index, By Country – 2022-2032 Figure 71: Asia Pacific Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032 Figure 72: Asia Pacific Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022–2032), US$ Mn Figure 73: Asia Pacific Market Share, By Type, 2022 & 2032 Figure 74: Asia Pacific Market Y-o-Y Growth Projections, By Type – 2022-2032 Figure 75: Asia Pacific Market Attractiveness Index, By Type – 2022-2032 Figure 76: Asia Pacific Market Share, By End-User, 2022 & 2032 Figure 77: Asia Pacific Market Y-o-Y Growth Projections, By End-User – 2022-2032 Figure 78: Asia Pacific Market Attractiveness Index, By End-User – 2022-2032 Figure 79: Asia Pacific Market Share, By Medical Application, 2022 & 2032 Figure 80: Asia Pacific Market Y-o-Y Growth Projections, By Medical Application – 2022-2032 Figure 81: Asia Pacific Market Attractiveness Index, By Medical Application – 2022-2032 Figure 82: Asia Pacific Market Share, By Country, 2022 & 2032 Figure 83: Asia Pacific Market Y-o-Y Growth Projections, By Country – 2022-2032 Figure 84: Asia Pacific Market Attractiveness Index, By Country – 2022-2032 Figure 85: US Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 86: US Market Share, By Type, 2021 Figure 87: US Market Share, By End-User, 2021 Figure 88: US Market Share, By Medical Application, 2021 Figure 89: Canada Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 90: Canada Market Share, By Type, 2021 Figure 91: Canada Market Share, By End-User, 2021 Figure 92: Canada Market Share, By Medical Application, 2021 Figure 93: Brazil Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 94: Brazil Market Share, By Type, 2021 Figure 95: Brazil Market Share, By End-User, 2021 Figure 96: Brazil Market Share, By Medical Application, 2021 Figure 97: Mexico Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 98: Mexico Market Share, By Type, 2021 Figure 99: Mexico Market Share, By End-User, 2021 Figure 100: Mexico Market Share, By Medical Application, 2021 Figure 101: Germany Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 102: Germany Market Share, By Type, 2021 Figure 103: Germany Market Share, By End-User, 2021 Figure 104: Germany Market Share, By Medical Application, 2021 Figure 105: U.K. Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 106: U.K. Market Share, By Type, 2021 Figure 107: U.K. Market Share, By End-User, 2021 Figure 108: U.K. Market Share, By Medical Application, 2021 Figure 109: France Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 110: France Market Share, By Type, 2021 Figure 111: France Market Share, By End-User, 2021 Figure 112: France Market Share, By Medical Application, 2021 Figure 113: Italy Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 114: Italy Market Share, By Type, 2021 Figure 115: Italy Market Share, By End-User, 2021 Figure 116: Italy Market Share, By Medical Application, 2021 Figure 117: BENELUX Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 118: BENELUX Market Share, By Type, 2021 Figure 119: BENELUX Market Share, By End-User, 2021 Figure 120: BENELUX Market Share, By Medical Application, 2021 Figure 121: Nordic Countries Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 122: Nordic Countries Market Share, By Type, 2021 Figure 123: Nordic Countries Market Share, By End-User, 2021 Figure 124: Nordic Countries Market Share, By Medical Application, 2021 Figure 125: China Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 126: China Market Share, By Type, 2021 Figure 127: China Market Share, By End-User, 2021 Figure 128: China Market Share, By Medical Application, 2021 Figure 129: Japan Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 130: Japan Market Share, By Type, 2021 Figure 131: Japan Market Share, By End-User, 2021 Figure 132: Japan Market Share, By Medical Application, 2021 Figure 133: South Korea Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 134: South Korea Market Share, By Type, 2021 Figure 135: South Korea Market Share, By End-User, 2021 Figure 136: South Korea Market Share, By Medical Application, 2021 Figure 137: GCC Countries Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 138: GCC Countries Market Share, By Type, 2021 Figure 139: GCC Countries Market Share, By End-User, 2021 Figure 140: GCC Countries Market Share, By Medical Application, 2021 Figure 141: South Africa Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 142: South Africa Market Share, By Type, 2021 Figure 143: South Africa Market Share, By End-User, 2021 Figure 144: South Africa Market Share, By Medical Application, 2021 Figure 145: Turkey Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 146: Turkey Market Share, By Type, 2021 Figure 147: Turkey Market Share, By End-User, 2021 Figure 148: Turkey Market Share, By Medical Application, 2021
Recommendations
Explore Healthcare Insights
View Reports